Impact of Co-existing Paroxysmal Atrial Fibrillation on Different Outcomes of Hospitalized COVID-19 Patients: Nationwide Inpatient Sample Analysis (2020) With Propensity Score Matching.

Autor: Teaima T; Department of Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL., Shoura S; Department of Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL., Gajjar RA; Department of Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL., Khalil C; Department of Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL., Atluri R; Department of Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL., Aziz I; Department of Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL., Shilbayeh AR; Department of Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL., Battikh N; Department of Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL., Huang HD; Section of Electrophysiology, Division of Cardiology, Department of Medicine, Rush medical center, Chicago, IL. Electronic address: henry_d_huang@rush.edu.
Jazyk: angličtina
Zdroj: Current problems in cardiology [Curr Probl Cardiol] 2023 Nov; Vol. 48 (11), pp. 101992. Date of Electronic Publication: 2023 Jul 22.
DOI: 10.1016/j.cpcardiol.2023.101992
Abstrakt: Various studies in the medical literature reported significant cardiovascular involvement in patients with coronavirus disease 2019 (COVID-19) pneumonia. Atrial fibrillation (AF) was identified as the most commonly observed arrhythmia complicating COVID-19 infection with an increased risk of short-term mortality. We used the National Inpatient Sample Database (NIS) of 2020 to conduct this retrospective cohort study. Our study's population consisted of adult patients hospitalized for COVID-19 Pneumonia with or without the presence of paroxysmal atrial fibrillation (PAF). Encounters with COVID-19 and co-existing PAF had higher adjusted odds of inpatient mortality (Adjusted odds ratio [aOR]: 1.19, 95% CI: 1.11-1.28, P < 0.001), longer mean length of hospital stay (LOS) of 1.17 days (95% confidence interval [CI]: 1.03-1.38, P < 0.001), and higher odds of different in-hospital complications. Based on these results, conducting more prospective/retrospective cohort studies with an emphasis on long-term follow-up on patients who develop PAF following COVID-19 infection is warranted.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2023 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: